Try Alerts Free   |   Login
Materials › Plastics Products, Nec

ATR Price Correlated With Financials For AptarGroup

Free historical financial statements for AptarGroup Inc.. See how revenue, income, cash flow, and balance sheet financials have changed over 47 quarters since 2011. Compare with ATR stock chart to see long term trends.

ATR Stock Compared to Quarterly

ATR Income Statement

Revenue, Net:836860000
Revenue Per Share:12.8113
Total Operating Expenses:741675000
Operating Income:95185000
Income Taxes:30738000
Net Income:54244000
Earnings Per Share, Basic:0.83
Shares Outstanding, Basic Avg:65322000

ATR Cash Flow

Operating Activities Net Income:
Depreciation, Depletion & Amortization:57601000
Net Cash from Operations:129695000
Net Cash from Operations Per Share:1.9855
Repurchases/Buybacks Common Stock:19241000
Issuance of Long-term Debt:4306000
Cash Dividends Paid:24829000
Net Cash from Financing Activities:-161490000
Property, Plant & Equipment Purchases:78869000
Purchases of Businesses, Net of Cash:null
Net Cash from Investing Activities:-83275000
Net Change in Cash & Equivalents:-114662000

ATR Balance Sheet

Cash and Cash Equivalents:125812000
Short-Term Investments:0
Inventories:462752000
Total Current Assets:1399734000
Property, Plant & Equipment, Net:1225800000
Total Assets:4026472000
Total Short-Term Liabilities:896652000

Insider Trading

 
Change
Value
Transaction
SEC Form 4
Trerotola Matthew L.   Director
3,170 sh at $94
$299,504
Buy

Major Holders (from 13F filings)

Investment Type
Change
Value (x$1000)
increase or decrease
Vanguard Group Inc
6,967,358 sh
16,705 sh
0%
$662,107
-$55,269
Blackrock Inc.
5,640,648 sh
-37,884 sh
-1%
$536,032
-$50,049
State Farm Mutual Automobile Insurance Co
4,744,564 sh
 
$450,876
State Street Corp
3,159,250 sh
171,060 sh
6%
$300,224
-$8,187
Atlanta Capital Management Co L L C
2,884,168 sh
-3,067 sh
0%
$274,082
-$23,910
Victory Capital Management Inc
2,883,322 sh
571,194 sh
25%
$274,002
$35,367
Champlain Investment Partners, LLC
1,774,420 sh
-37,850 sh
-2%
$168,623
-$18,421
Rivulet Capital, LLC
1,692,500 sh
-176,700 sh
-9%
$160,838
-$58,793
JPMorgan Chase & Co
1,511,341 sh
-77,753 sh
-5%
$143,622
-$20,388
Neuberger Berman Group LLC
1,287,368 sh
-7,205 sh
-1%
$122,337
-$11,276
Boston Trust Walden Corp
1,242,035 sh
4,427 sh
0%
$118,030
-$9,704
London Co Of Virginia
1,121,730 sh
-5,529 sh
0%
$106,598
-$9,747
Geode Capital Management, LLC
1,104,117 sh
35,938 sh
3%
$105,525
-$4,721
Northern Trust Corp
1,020,877 sh
-41,096 sh
-4%
$97,014
-$27,768
Allspring Global Investments Holdings, LLC
1,019,717 sh
15,968 sh
2%
$96,903
-$6,693
Mawer Investment Management Ltd.
776,943 sh
1,545 sh
0%
$73,833
-$6,196
Bank Of New York Mellon Corp
720,324 sh
-1,759 sh
0%
$68,452
-$6,075
Williams Jones Wealth Management, LLC.
700,246 sh
-37,432 sh
-5%
$66,544
-$9,592
Nuance Investments, LLC
666,365 sh
4,869 sh
1%
$63,325
-$4,948
Dimensional Fund Advisors LP
631,259 sh
4,774 sh
1%
$59,993
-$4,665
COMPANY PROFILE
SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES BASIS OF PRESENTATION

The accompanying consolidated financial statements include the accounts of AptarGroup, Inc. and our subsidiaries. The terms “AptarGroup”, “Aptar”, “Company”, “we”, “us” or “our” as used herein refer to AptarGroup, Inc. and our subsidiaries. All significant intercompany accounts and transactions have been eliminated. Certain previously reported amounts have been reclassified to conform to the current period presentation.

AptarGroup’s organizational structure consists of three market-focused business segments which are Pharma, Beauty + Home and Food + Beverage. This is a strategic structure which allows us to be more closely aligned with our customers and the markets in which they operate.

In late 2017, we began a business transformation plan to drive profitable sales growth, increase operational excellence, enhance our approach to innovation and improve organizational effectiveness (see Note 21 – Restructuring Initiatives for further details). The primary focus of the plan is the Beauty + Home segment; however, certain global general and administrative functions have also been addressed. During 2021, 2020 and 2019, we recognized approximately $23.2 million, $26.5 million and $20.5 million, respectively, of restructuring costs related to this plan. As of December 31, 2021, we have successfully completed the vast majority of our planned initiatives related to this plan and do not expect any significant, additional restructuring expenses related to this plan.

Beginning July 1, 2018, we have applied highly inflationary accounting for our Argentinian subsidiary pursuant to U.S. GAAP. We have changed the functional currency from the Argentinian peso to the U.S. dollar. We remeasure our peso denominated assets and liabilities using the official rate. In September 2019, the President of Argentina reinstituted exchange controls restricting foreign currency purchases in an attempt to stabilize Argentina’s financial markets. As a result of these currency controls, a legal mechanism known as the Blue Chip Swap emerged in Argentina for reporting entities to transfer U.S. dollars. The Blue Chip Swap rate has diverged significantly from Argentina’s “official rate” due to the economic environment. During the second quarter of 2020, we transferred U.S. dollars into Argentina through the Blue Chip Swap method and we recognized a gain of $1.0 million. This gain helped to offset foreign currency losses due to our Argentinian peso exposure and devaluation against the U.S. dollar. During the third quarter of 2021, we utilized the Blue Chip Swap and recognized a gain of $1.4 million. Our Argentinian operations contributed less than 2.0% of consolidated net assets and revenues at and for the year ended December 31, 2021.

The extent to which the COVID-19 pandemic impacts our financial results and operations for fiscal year 2022 and going forward for all three of our business segments will depend on future developments which are highly uncertain and cannot be predicted, including the availability, adoption, and efficacy of vaccines and boosters, the length of time it takes for normal economic and operating conditions to resume, additional governmental actions that may be taken and/or extended in response to any further resurgence of the virus and numerous other uncertainties. No impairments were recorded as of December 31, 2021 related to the COVID-19 pandemic. However, due to the general uncertainty surrounding the situation, including areas such as cost inflation, supply chain disruptions, and labor shortages, future results could be negatively affected by the pandemic and therefore our results could be materially impacted.

ACCOUNTING ESTIMATES

The financial statements are prepared in conformity with accounting principles generally accepted in the United States of America (“U.S. GAAP”). This process requires management to make estimates and assumptions that affect the reported amo

Data imported from AptarGroup Inc. SEC filings. Check original filings before making any investment decision.